story of the week
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
N. Engl. J. Med 2015 Sep 17;[EPub Ahead of Print], B Zinman, C Wanner, JM Lachin, D Fitchett, E Bluhmki, S Hantel, M Mattheus, T Devins, OE Johansen, HJ Woerle, UC Broedl, SE InzucchiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.